CRIA faculty members comprise a dynamic research community at UB who make news with their breakthroughs in studying the causes, consequences and biology of addiction.
Kenneth E. Leonard, PhD, director of UB’s Clinical and Research Institute on Addictions, has been appointed to the Program Advisory Board of the National Consortium on Alcohol and Neurodevelopment in Adolescent-Adulthood (NCANDA-A).
Channavix Therapeutics and Peregrine BioVentures are developing two patent families related to long-lasting, non-opioid, non-addictive pain therapeutics.
UB’s Clinical and Research Institute on Addictions (CRIA) is a long-standing national leader in the study of alcohol and substance abuse. For nearly 50 years, CRIA has conducted groundbreaking research on significant addiction issues, including:
Part of UB’s Downtown Campus, CRIA is a key contributor to UB’s reputation for research excellence and a proud member of the Buffalo Niagara Medical Campus.